Role of leukotrienes and platelet activating factor in allergic bronchoconstriction and their interactions in guinea pig airway in vivo

Touvay, 1985, Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba, Agents actions, 17, 371, 10.1007/BF01982650 Santives, 1976, Immunologically induced disease in guinea pig, J Allergy Clin Immunol, 57, 582, 10.1016/0091-6749(76)90010-5 Konzett, 1940, Versuchanordung zu Untersuchungen an der Bronchialmusukulatur, Arch Exp Pathologie Pharmakologie, 195, 71, 10.1007/BF01861842 Jones, 1982, Biological activity of leukotriene sulfones of respiratory tissues, Prostaglandins, 24, 279, 10.1016/0090-6980(82)90154-X Fujimra, 1983, Inhibitory effects of steroids on slow reacting substance of anaphylaxis (SRS-A) mediated bronchoconstriction if guinea pig in vivo, Arerogi, 32, 365 Minami, 1982, A new quantitative inhalation apparatus for small animals, Japanese Journal of Chest Disease, 21, 252 Kellaway, 1940, The liberation of a slow reacting smooth muscle stimulating substance of anaphylaxis, Q J Exp Physiol, 30, 121, 10.1113/expphysiol.1940.sp000825 Dahlen, 1980, Leukotrienes are potent constrictors of human bronchi, Nature, 228, 484, 10.1038/288484a0 Peck, 1981, The effects of leukotrienes C4 and D4 on the microvascular leakage of guinea pigs, Prostaglandins, 21, 315, 10.1016/0090-6980(81)90149-0 Marom, 1982, Slow reacting substances leukotriene C4 and D4, increase the release of mucus from human airways in vivo, Am Rev Respir Dis, 126, 449 Pinckard, 1979, Physiochemical and functional identity to rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils, J Immunol, 123, 1847 Vargaftig, 1980, Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives, Eur J Pharmacol, 65, 185, 10.1016/0014-2999(80)90391-X Tokuyama, 1991, Mechanism of airway narrowing caused by inhaled platelet-activating factor: Role of airway microvascular leakage, Am Rev Resp Dis, 143, 1345, 10.1164/ajrccm/143.6.1345 Lellouch-Tubiana, 1988, Eosinophil recruitment into guinea pig lung after PAF-acether and allergen administration: modulation by prostacylin, platelet depletion, and selective antagonist, Am Rev Resp Dis, 137, 948, 10.1164/ajrccm/137.4.948 Kroegel, 1989, Platelet activating factor induces eosinophil peroxidase release from purified human eosinophils, Immunology, 142, 3518 Cuss, 1986, Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man, Lancet, 2, 189, 10.1016/S0140-6736(86)92489-X Darius, 1985, Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis, Science, 232, 58, 10.1126/science.3082008 Casals-Stenzel, 1987, Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis, Immunopharmacology, 13, 117, 10.1016/0162-3109(87)90048-8 Fitzgerald, 1985, The release of PAF acether and lyso-PAF from sensitized guinea-pig lungs, Br J Pharmacol, 86, 573 Lagente, 1987, Interference of the PAF-acether antagonist BN52021 with passive anaphylaxis in the guinea-pig, Prostaglandins, 33, 265, 10.1016/0090-6980(87)90011-6 Voelkel, 1982, Nonimmunological production of leukotrienes induced by platelet-activating factor, Science, 218, 286, 10.1126/science.7123233 Bonnet, 1983, Dependency of the PAF-acether induced bronchospasm on the lipoxygenase pathway in the guinea pig, Prostaglandins, 26, 457, 10.1016/0090-6980(83)90180-6 Vargaftig, 1980, Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives, Eur J Pharmacol, 65, 185, 10.1016/0014-2999(80)90391-X Lefort, 1984, The platelet-independent release of thromboxane A2 by Paf-acether from guinea pig involves mechanisms distinct from those for leukotriene, Br J Pharmacol, 82, 565, 10.1111/j.1476-5381.1984.tb10795.x